Sign in
Taking people in United StatesNo phase

A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD

Key facts

Who runs it
United States Department of Defense
Where
Charleston, Minneapolis, Phoenix, and San Diego, United StatesSee the 4 sites
Trial code
Status
Recruiting
People taking part
420 people, planned
Started
16 May 2025
Expected to end
31 Aug 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Partnered Prolonged Exposure (PPE)
  • Prolonged Exposure (PE)
Record updated
11 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Post-9/11 Veteran Enrolled in VHA
  • 1 > mo stable medication
  • Committed relationship 6+ months
  • DSM-5-R PTSD Diagnosis

Who cannot take part

  • Mania, psychosis, or severe substance use disorder, past 3 mos
  • Severe cognitive impairment
  • Imminent suicidality/homicidally
  • Severe intimate partner violence in last 6 months
  • Fear of or intimidation by partner
  • Partner screens positive for PTSD

Where in United States

  • Charleston VA Healthcare SystemCharleston, United StatesContact: Sarah SzafranskiNot yet recruiting
  • Minneapolis VA Healthcare SystemMinneapolis, United StatesContact: Emily M Hudson, PhDNot yet recruiting
  • Phoenix VA Healthcare SystemPhoenix, United StatesContact: Donald LemonNot yet recruiting
  • San Diego VA Healthcare SystemSan Diego, United StatesContact: Alex LinTaking people

About the trial

What the trial wants to find out

PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are not equally effective for everyone. An important minority (~40%) will retain their PTSD diagnoses after treatment, and many discontinue treatment prematurely, especially post-9/11 Service Members. TFTs are also more effective in addressing symptoms than psychosocial functioning. More work is needed to improve the consistency and potency of TFTs. Partnering with significant others may provide a powerful method for helping individuals get more out of their PTSD treatment. Observational research shows that relationship factors can help patients initiate, stay in, and experience greater benefit from PTSD treatment. Veterans that were surveyed experienced greater treatment gains when they shared more about their treatment with loved ones and when loved ones accommodated less for PTSD symptoms. Despite the promise of partner-involved interventions, there is no couples approach to PTSD treatment that has demonstrated superior outcomes to individual-only treatment models (i.e., TFTs). To address this gap, the investigators have completed a series of partner-assisted PTSD treatment studies, leading up the current proposal (Partnered PE, PPE). The investigators found that treatment completion rates were better than routine clinical care, and the treatment led to large improvements in participants' functioning, PTSD symptoms, and romantic functioning. For this proposed study, the primary objective is to conduct a randomized controlled trial (Research Level 3; larger-scale clinical trial) to test the superiority of PPE to standard PE among post 9/11 Veterans. The investigator's primary hypothesis is that PPE will lead to greater improvements in psychosocial functioning than standard PE. Secondary and tertiary aims examine posttreatment clinical outcomes (PTSD, depression) and intimate partner outcomes (relationship functioning, distress, caregiver burden, and psychosocial functioning), as well as examine strategies for PPE implementation. In exploratory aims, the investigators will examine the stability of group differences, treatment completion rates, the role military sexual trauma history, and treatment mechanisms.

The 2 groups in the trial

  • Prolonged Exposure (PE)Existing treatment, for comparison
  • Partnered Prolonged Exposure (PPE)Treatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
11 September 2026